MyFinsight
Home
Blog
About
Back
Income Statement
Eikon Therapeutics, Inc. (EIKN)
Eikon Therapeutics, Inc. (EIKN)
source: myfinsight.com
Net loss
attributable to common...
-$88,409K
Net loss and
comprehensive loss
-$88,409K
Interest income
(expense), net
$5,037K
Loss from operations
-$93,394K
Other income
(expense), net
-$52K
Total operating
expenses
$93,394K
Research and development
$75,460K
General and
administrative
$17,934K
Back